Market Snapshot

BSE Sensex: 85267.66 0.53%
BSE 500: 37228.82 0.72%
BSE 200: 11752.7 0.68%
BSE 100: 27246.8 0.61%
BSE MidCap: 46477.51 1.14%
BSE SmallCap: 50890.67 0.65%
BSE BANKEX: 66662.68 0.30%
BSE IT: 37004.68 0.45%
Nifty 50: 26046.95 0.57%
Nifty 500: 23726.2 0.74%
Nifty 200: 14469.3 0.72%
Nifty 100: 26565.1 0.62%
Nifty Midcap 100: 60283.3 1.18%
Nifty Small 100: 17389.95 0.94%
Nifty IT: 38274.75 0.47%
Nifty PSU Bank: 8247.8 0.15%

News:

United Drilling Tools secures ...
Biocon?s arm inks pact to comm...
GPT Infraprojects secures Rs 5...
KEC International bags Rs 1,15...
Astra Microwave Products bags ...

Abbott India Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

12 Dec 2025 | 03:59 PM

27,959.55

-268.55 (-0.95%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-2.44%

Return (1Y)

Underperformed BSE Healthcare by 2.23%
More Volatile

1.54%

Standard Deviation (1Y)

Higher than BSE Healthcare by 0.57%
Inconsistent Performer

3/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

35,922

25,260

News & Announcements

Abbott India gets central govt nod to appoint Kartik Rajendran as MD
20 days ago

Abbott India gets central govt nod to appoint Kartik Rajendran as MD

25 - Nov - 2025 12:00 | 20 days ago

His tenure will be for a period of five years, effective from 14 June 2025, to 13 June 2030.
The appointment is expected to provide continued strategic leadership and drive growth initiatives for the company in the coming years.
Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.
Abbott India?s standalone net profit climbed 15.79% to Rs 415.27 crore on 7.62% increase in revenue from operations to Rs 1,757.15 crore in Q2 FY26 over Q2 FY25.
Shares of Abbott India shed 0.63% to currently trade at Rs 29,536.05 on the BSE.
Powered by Capital Market - Live News
Abbott India receives Central Govt. approval for appointment of MD
21 days ago

Abbott India receives Central Govt. approval for appointment of MD

24 - Nov - 2025 12:00 | 21 days ago

Abbott India has received approval from the Central Government under Section 196 of the Companies Act, 2013 for the appointment of Kartik Rajendran (DIN: 09527717) as the Managing Director of the Company, for a period of 5 (five) years, with effect from 14 June 2025 to 13 June 2030.
Powered by Capital Market - Live News
Abbott India standalone net profit rises 15.80% in the September 2025 quarter
38 days ago

Abbott India standalone net profit rises 15.80% in the September 2025 quarter

07 - Nov - 2025 12:00 | 38 days ago

Net profit of Abbott India rose 15.80% to Rs 415.27 crore in the quarter ended September 2025 as against Rs 358.61 crore during the previous quarter ended September 2024. Sales rose 7.62% to Rs 1757.15 crore in the quarter ended September 2025 as against Rs 1632.67 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 1757.15 1632.67 8

OPM % 28.58 26.89 -

PBDT 564.57 496.94 14

PBT 545.93 479.43 14

NP 415.27 358.61 16

Powered by Capital Market - Live News
Abbott India Q2 PAT jumps 16% YoY to Rs 415 cr
39 days ago

Abbott India Q2 PAT jumps 16% YoY to Rs 415 cr

06 - Nov - 2025 12:00 | 39 days ago

Profit before tax (PBT) stood at Rs 545.93 crore in Q2 FY26, up 13.87% year on year (YoY).
Total expenses increased 5.55% to Rs 1,281.17 crore in Q2 FY26 as against Rs 1,213.72 crore posted in same quarter last year. The cost of materials consumed stood at Rs 162.59 crore (down 5.50% YoY), employee benefit expense was at Rs 158.98 crore (up 7.85% YoY) and finance cost was at Rs 7.55 crore (up 202% YoY) during the period under review.
Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.
Shares of Abbott India rose 0.77% to settle at Rs 29,593.20 on the BSE.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Abbott India Ltd has decreased by -4.36% since past 3 Months
FII shareholding in Abbott India Ltd has decreased by -4.42% since past 1 Year
GovT shareholding in Abbott India Ltd has decreased by -100% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1757.15	1632.67	8
OPM %	28.58	26.89	-
PBDT	564.57	496.94	14
PBT	545.93	479.43	14
NP	415.27	358.61	16

General Notifications

My Notifications

Research Notifications

Abbott India Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

27,959.55 -268.55 (-0.95%)

News & Announcements

Price vs Volume

Stock Trivia

Abbott India Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

27,959.55

-268.55 (-0.95%)